V. A. Ridin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
V. A. Ridin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- K. M. Figurin
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
4 shared publications - Vsevolod Borisovich Matveev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
4 shared publications - Vitalii A. Cherniaev
Moscow State Budgetary Healthcare Institution «Moscow City Hospital named after S.S. Yudin, Moscow Healthcare Department
3 shared publications - A. V. Klimov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Aleksey V. Klimov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
1 shared publication - Andrey A. Kirichek
Moscow City Oncological Hospital No. 62, Moscow Healthcare Department
1 shared publication
Latest Publications
- Open Access
- 30 December 2019
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 15 (4) , 39-49-49
Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?
Objective: to compare the results of partial (PN) and radical nephrectomy (RN) in patients with renal parenchymal tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney.Materials and methods. Medical data of 114 consecutive patients with renal cell carcinoma (RCC) cT1–3aN0M0 and functioning contralateral kidney were included into the study: 57 (50.0 %) persons undergone PN for tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 (the main group), and 57 (50.0 %) patients undergone RN (the control group). The groups were comparable with regards to demographic characteristics, nephrometric parameters, morphological tumor features, and baseline glomerular filtration rate (р 0.05 for all). Median follow-up – 52.0 ± 23.6 (9.1–138.5) months.Results. Technically complicated PNs were associated with an increase of median surgery time (by 39 min, р = 0.06), blood loss (by 319 ml, p within the groups. Chronic kidney disease (CKD) progression rate was significantly higher in RN than in PN group (40 % vs 31.6 % respectively, р = 0.050), including more frequent development of CKD stages III–IV (31.6 % vs 26.3 % respectively; р = 0.034). There was no difference of long-term survival between PN and RN groups, and that included survival results stratified according to gender, age, baseline CKD stage, PADUA and RENAL indexes. Five-year recurrence-free survival was 94.1 % vs 92.2 % (р = 0.223), cancer-specific survival – 92.3 % vs 90.8 % (р = 0.443), cardio-specific survival – 91.6 % vs 77.9 % (р = 0.549), overall survival – 89.8 % vs 70.7 % respectively (р = 0.858).Conclusion. PN is effective and safe method of treatment in patients with renal parenchymal tumors with PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney, providing significant functional benefit without survival compromising when compared with RN.
- 30 December 2019
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 15 (4) , 39-49-49
Open AccessIs technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?
Objective: to compare the results of partial (PN) and radical nephrectomy (RN) in patients with renal parenchymal tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney.Materials and methods. Medical data of 114 consecutive patients with renal cell carcinoma (RCC) cT1–3aN0M0 and functioning contralateral kidney were included into the study: 57 (50.0 %) persons undergone PN for tumors with nephrometric PADUA index ≥8 and/or RENAL index ≥7 (the main group), and 57 (50.0 %) patients undergone RN (the control group). The groups were comparable with regards to demographic characteristics, nephrometric parameters, morphological tumor features, and baseline glomerular filtration rate (р 0.05 for all). Median follow-up – 52.0 ± 23.6 (9.1–138.5) months.Results. Technically complicated PNs were associated with an increase of median surgery time (by 39 min, р = 0.06), blood loss (by 319 ml, p within the groups. Chronic kidney disease (CKD) progression rate was significantly higher in RN than in PN group (40 % vs 31.6 % respectively, р = 0.050), including more frequent development of CKD stages III–IV (31.6 % vs 26.3 % respectively; р = 0.034). There was no difference of long-term survival between PN and RN groups, and that included survival results stratified according to gender, age, baseline CKD stage, PADUA and RENAL indexes. Five-year recurrence-free survival was 94.1 % vs 92.2 % (р = 0.223), cancer-specific survival – 92.3 % vs 90.8 % (р = 0.443), cardio-specific survival – 91.6 % vs 77.9 % (р = 0.549), overall survival – 89.8 % vs 70.7 % respectively (р = 0.858).Conclusion. PN is effective and safe method of treatment in patients with renal parenchymal tumors with PADUA index ≥8 and/or RENAL index ≥7 and functioning contralateral kidney, providing significant functional benefit without survival compromising when compared with RN.
- 1 November 2019
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 11 (3)
Results of kidney resection in patients with renal cell cancer with a high nephrometric index
Резекция почки является общепризнанным стан дартом в лечении больных клинически локализо ванными опухолями почечной паренхимы. Со вершенствование операционной техники привело к накоплению опыта технич
- 1 November 2019
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 11 (3)
Results of kidney resection in patients with renal cell cancer with a high nephrometric index
Резекция почки является общепризнанным стан дартом в лечении больных клинически локализо ванными опухолями почечной паренхимы. Со вершенствование операционной техники привело к накоплению опыта технич
- Open Access
- 30 September 2019
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 15 (3) , 156-159-159
Clinical case of lymphoma of the seminal vesicle
The article presents a clinical case of seminal vesicle lymphoma in a 73-year-old man who was sent for examination at the N.N. Blokhin National Medical Research Center of Oncology with suspected prostate tumor.
- 30 September 2019
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 15 (3) , 156-159-159
Open AccessClinical case of lymphoma of the seminal vesicle
The article presents a clinical case of seminal vesicle lymphoma in a 73-year-old man who was sent for examination at the N.N. Blokhin National Medical Research Center of Oncology with suspected prostate tumor.
- 8 November 2018
- Published by Elsevier in European Urology Supplements
- Vol. 17 (14) , e2937
Long-term functional results of partial nephrectomy in patients with tumors of solitary kidney
- 8 November 2018
- Published by Elsevier in European Urology Supplements
- Vol. 17 (14) , e2937
Long-term functional results of partial nephrectomy in patients with tumors of solitary kidney
- Open Access
- 15 September 2018
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 20 (3) , 51-54
Clinical prognostic factors of bilateral synchronous renal cancer
The aim of the study is to assess the positive and negative prognostic factors of survival in patients with bilateral synchronous renal cancer (BRC). Materials and methods. The study was conducted on the basis of N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. Cohort of patients with the synchronous BRC consisted of 160 patients between 1996 and 2014. All patients after finishing treatment were observed on an ambulatory basis during the period from 11 months to 12 years (median follow-up 81.05±46.7 months). We studied factors affecting 5-year survival rate, both positive and negative. Statistical analysis of the obtained results carried out using generally accepted statistical methods such as SPSS 23.0 - block of programs for Windows. Results. In case of synchronous BRC in 2/3 (65%) of patients the first kidney was operated on using organ-preserving surgery, in 1/4 of patients (n=21, 26.2%) both kidneys were operated on using organ-preserving surgery. In case of synchronous renal cancer the best results of survival, but without statistical significance (p=0.112) had patients with bilateral renal cancer who operated on using organ-preserving surgery. The 10-year overall survival in this group of patients was 90.5% in comparison with 62.5% - when nephrectomy was performed on the first stage and 76.4% in patients who had nephrectomy performed because of the renal cancer in the second kidney. Conclusions. The main factors affecting the 5-year survival rate of patients with synchronous BRC were: smoking, primary tumor size, age and type of surgery.
- 15 September 2018
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 20 (3) , 51-54
Open AccessClinical prognostic factors of bilateral synchronous renal cancer
The aim of the study is to assess the positive and negative prognostic factors of survival in patients with bilateral synchronous renal cancer (BRC). Materials and methods. The study was conducted on the basis of N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation. Cohort of patients with the synchronous BRC consisted of 160 patients between 1996 and 2014. All patients after finishing treatment were observed on an ambulatory basis during the period from 11 months to 12 years (median follow-up 81.05±46.7 months). We studied factors affecting 5-year survival rate, both positive and negative. Statistical analysis of the obtained results carried out using generally accepted statistical methods such as SPSS 23.0 - block of programs for Windows. Results. In case of synchronous BRC in 2/3 (65%) of patients the first kidney was operated on using organ-preserving surgery, in 1/4 of patients (n=21, 26.2%) both kidneys were operated on using organ-preserving surgery. In case of synchronous renal cancer the best results of survival, but without statistical significance (p=0.112) had patients with bilateral renal cancer who operated on using organ-preserving surgery. The 10-year overall survival in this group of patients was 90.5% in comparison with 62.5% - when nephrectomy was performed on the first stage and 76.4% in patients who had nephrectomy performed because of the renal cancer in the second kidney. Conclusions. The main factors affecting the 5-year survival rate of patients with synchronous BRC were: smoking, primary tumor size, age and type of surgery.
- 1 March 2018
- Published by Elsevier in European Urology Supplements
- Vol. 17 (2) , e739
Striking a balance between renal ischemia and excessive blood loss decreases risk of acute kidney injury following partial nephrectomy of solitary kidney
- 1 March 2018
- Published by Elsevier in European Urology Supplements
- Vol. 17 (2) , e739
Striking a balance between renal ischemia and excessive blood loss decreases risk of acute kidney injury following partial nephrectomy of solitary kidney